Literature DB >> 20368303

JNK signalling in human and experimental renal ischaemia/reperfusion injury.

John Kanellis1, Frank Y Ma, Rangi Kandane-Rathnayake, John P Dowling, Kevan R Polkinghorne, Brydon L Bennett, Glenn C Friedman, David J Nikolic-Paterson.   

Abstract

BACKGROUND: Ischaemia/reperfusion (I/R) is an important factor in delayed graft function in renal transplantation and is a determinant of long-term graft outcome. This study examined the role of c-Jun N-terminal kinase (JNK) signalling in human and experimental renal I/R injury.
METHODS: Biopsies obtained 15-20 min after reperfusion of human renal allografts were examined for JNK signalling by immunostaining for phospho-c-Jun. To examine the pathologic role of JNK signalling, a selective JNK inhibitor (CC-401) was administered to rats before or after the induction of a 30-min period of bilateral renal ischaemia followed by reperfusion. Renal function and tubular damage were analysed.
RESULTS: Substantial JNK activation was evident in tubular epithelial cells in kidneys from deceased donors (n = 30) which was less prominent in kidneys from live donors (n = 7) (44.6 +/- 24.8% vs 29.1 +/- 20% p-c-Jun+, respectively; P < 0.05), whereas biopsies of thin basement membrane disease exhibited little, or no, p-c-Jun staining. The degree of p-c-Jun staining correlated with ischaemic time in deceased donor allografts, but not with graft function. Administration of CC-401 to rats prior to bilateral renal I/R prevented acute renal failure and largely prevented tubular damage, leucocyte infiltration and upregulation of pro-inflammatory molecules. However, delaying CC-401 treatment until 1 h after reperfusion (after the peak of JNK activation) had no protective effect.
CONCLUSIONS: We have identified acute activation of the JNK signalling pathway following I/R in human kidney allografts. Experimental studies indicate that blockade of JNK signalling, commenced prior to this activation, can prevent acute tubular necrosis and renal dysfunction secondary to I/R injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368303     DOI: 10.1093/ndt/gfq147

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

1.  PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.

Authors:  Rongpei Lan; Hui Geng; Aaron J Polichnowski; Prajjal K Singha; Pothana Saikumar; Donald G McEwen; Karen A Griffin; Robert Koesters; Joel M Weinberg; Anil K Bidani; Wilhelm Kriz; Manjeri A Venkatachalam
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

2.  Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor.

Authors:  Nancy-Ellen Haynes; Nathan R Scott; Li C Chen; Cheryl A Janson; Jia Kui Li; Christine M Lukacs; Aruna Railkar; Effie Tozzo; Toni Whittard; Nicholas F Brown; Adrian Wai-Hing Cheung
Journal:  ACS Med Chem Lett       Date:  2012-08-08       Impact factor: 4.345

3.  Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.

Authors:  Yingfeng Shi; Liuqing Xu; Jinhua Tang; Lu Fang; Shuchen Ma; Xiaoyan Ma; Jing Nie; Xiaoling Pi; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

4.  Time-course full profiling of circulating miRNAs in neurologically deceased organ donors: a proof of concept study to understand the onset of the cytokine storm.

Authors:  Andrée-Anne Clément; Daphnée Lamarche; Marie-Hélène Masse; Cécilia Légaré; Lee-Hwa Tai; Laurence Fleury Deland; Marie-Claude Battista; Luigi Bouchard; Frédérick D'Aragon
Journal:  Epigenetics       Date:  2022-05-21       Impact factor: 4.861

5.  Inhibition of semaphorin-3a suppresses lipopolysaccharide-induced acute kidney injury.

Authors:  Xiaofang Tian; Hua Gan; Yizhou Zeng; Hongfei Zhao; Rong Tang; Yunfeng Xia
Journal:  J Mol Med (Berl)       Date:  2018-06-16       Impact factor: 4.599

Review 6.  TGF-β signaling via TAK1 pathway: role in kidney fibrosis.

Authors:  Mary E Choi; Yan Ding; Sung Il Kim
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

7.  The role of MAPK in drug-induced kidney injury.

Authors:  Hilary Cassidy; Robert Radford; Jennifer Slyne; Sein O'Connell; Craig Slattery; Michael P Ryan; Tara McMorrow
Journal:  J Signal Transduct       Date:  2012-03-12

8.  JNK, p38, ERK, and SGK1 Inhibitors in Cancer.

Authors:  Jonas Cicenas; Egle Zalyte; Arnas Rimkus; Dalius Dapkus; Remigijus Noreika; Sigitas Urbonavicius
Journal:  Cancers (Basel)       Date:  2017-12-21       Impact factor: 6.639

9.  The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.

Authors:  Masashi Okada; Kenta Kuramoto; Hiroyuki Takeda; Hikaru Watarai; Hirotsugu Sakaki; Shizuka Seino; Manabu Seino; Shuhei Suzuki; Chifumi Kitanaka
Journal:  Oncotarget       Date:  2016-05-10

Review 10.  TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease.

Authors:  Sung Il Kim; Mary E Choi
Journal:  Kidney Res Clin Pract       Date:  2012-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.